Northwest Biotherapeutics, Inc.

NWBO·OTC Markets OTCQB·Healthcare
Compare
0.17000.0000 (0.00%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.1700
Open0.1690
Day range0.15710.1846
52-week range0.14000.3400
Off day high−7.91%
Off 52-week high−50.00%
Volume4.27M
Avg. volume (3M)4.13M
Market cap289.96M
EPS (TTM)-0.0300
Forward P/E-2.43
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)-0.63
Shares outstanding1.71B
Short interest11.84% of float
Earnings dateNov 12, 2026 (est.)
Analyst target1.0000
Profit margin0.00%

Against its peers

Compare in full ›
NWBO DTC.CN VRXA ANIX CMPX NBP
Market cap 289.96M 25.50M 134.34M 114.03M 137.35M 117.16M
P/E (TTM) — — — — — —
Forward P/E -2.4 — — -10.6 -1.4 -0.8
Price/book -6.3 7.3 -0.7 7.8 0.8 0.6
Dividend yield — — — — — —
1-year change −32.00% −61.05% −90.96% −24.82% −80.29% −75.89%
Today 0.00% −1.47% −4.04% +7.36% +1.29% 0.00%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All NWBO news ›
BioBuzz··3 outletsPositive

Bethesda’s Northwest Biotherapeutics Partners With UK’s NHS Blood and Transplant to Support DCVax®-L Production

“NHSBT’s impressive expertise and facilities for advanced therapies are at the forefront of the field. We are very excited about collaborating with them on our DCVax®-L personalised immune therapies for cancer. We believe NHSBT’s…

More from 2 other outlets

From the 4Search news index, newest first.

In the news

2mentions in 30 days
2with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance